The Director-General of Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) says the AstraZeneca vaccine recently inaugurated and distributed to various countries has no side effect.
Prof. Mojisola Adeyeye, who received her vaccination in Abuja on Thursday noted that NAFDAC went through the application dossier of the vaccine before it was approved to be administered on Nigerians for the treatment of COVID-19.
“When we got the dossier or the application package of the vaccine, we went through it line by line. But before we got the application itself, we went through other assessments. I am talking about their assessment report so that we are prepared and guided when we start our own and that was exactly what happened.
We conclude based on quality, safety and efficacy because we have to depend on the report. This particular AstraZeneca vaccine, over 20,000 people were involved in phase three of the report,’’ she said.
Adeyeye said that the effectiveness of the AstraZeneca vaccine outweighs the risk, as it has already been scrutinized.
She noted that there was no medicine without its side effect; especially when still going through the developmental stage.
In a statement, National Primary Health Care Development Agency (NPHCDA) Executive Director Dr. Faisal Shuaib, also said that since the country commenced its COVID-19 vaccination, no Nigerian has observed any adverse reaction; noting that all side effects reported by those who have taken the jab have been mild.
“We are aware of precautionary concerns that have been raised regarding one specific batch of the AstraZeneca vaccine, namely ABV5300. We understand that investigations are being conducted to determine if the batch is in any way linked to an observed side effect.
While we await the outcome of the investigations; it is important to clearly state that Nigeria did not receive any doses from the batch of vaccines with issues.”
Dr. Faisal said the government is satisfied that the clinical evidence indicates that the Oxford-AstraZeneca vaccine is safe and effective.
“Our assessment is in line with countries such as Spain and the UK; who have indicated that they will continue to administer the vaccine because it remains an important tool to protect against COVID-19.
The safety of vaccines delivered to Nigeria is paramount to the Presidential Task Force on COVID-19. For this reason, it has enhanced multi-sectoral collaboration among stakeholders and technical entities; such as the Federal Ministry of Health (FMOH), NPHCDA, NAFDAC, the WHO and UNICEF; whose cooperation ensures the highest global standards are met for vaccines delivered to Nigeria before they are distributed to Nigerians. Clear, rigorous protocols are being followed to safeguard the health of Nigerians,” he noted.
(With input from agencies)